Security Snapshot

TELADOC HEALTH INC - NOTE 1.250% 6/0 Institutional Ownership

CUSIP: 87918AAF2

13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

49

Principal

$1,036,256,430

Price (% of par)

95.53%

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Debt / NOTE 1.250% 6/0
Market price (% of par)
95.53%
All holders as of 31 Mar 2026
Q1 2026
Total 13F principal
$1,036,256,430
Total reported market value
$995,443,046
Principal change
-$38,846,070
Market value change
-$35,755,161
Number of holders
49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • 87918AAF2 - TELADOC HEALTH INC - NOTE 1.250% 6/0 is tracked under CUSIP 87918AAF2.
  • 49 institutions reported positions in Q1 2026.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 50 to 49 between Q4 2025 and Q1 2026.
  • Reported value moved from $1,025,223,121 to $995,443,046.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 49 institutions filings for Q1 2026.

Open SEC Evidence

Security key

87918AAF2

Latest holder period

Q1 2026

13F holders

49

13D/G owners

0

CIK / CUSIP context first

As of 31 Mar 2026, 49 institutional investors reported holding $1,036,256,430 in principal (par value) of TELADOC HEALTH INC - NOTE 1.250% 6/0.

Institutional Holders of TELADOC HEALTH INC - NOTE 1.250% 6/0 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2026 Q1 $1,036,256,430 $995,443,046 -$35,755,161 95.53% 49
2025 Q4 $1,075,102,500 $1,025,223,121 +$147,261,894 95.0% 50
2025 Q3 $921,010,616 $863,754,375 -$19,277,647 93.48% 53
2025 Q2 $948,804,001 $876,418,076 +$52,242,458 92.24% 54
2025 Q1 $942,460,000 $866,320,179 -$11,256,742 91.62% 53
2024 Q4 $966,246,242 $846,509,905 -$66,918,054 87.37% 56
2024 Q3 $982,841,169 $852,006,927 +$168,481,863 86.38% 60
2024 Q2 $799,153,111 $664,910,332 +$60,593,763 82.88% 66
2024 Q1 $719,642,611 $608,415,259 +$14,208,820 84.25% 61
2023 Q4 $709,712,100 $585,594,454 +$15,135,623 82.2% 71
2023 Q3 $690,517,711 $553,197,185 +$7,342,819 79.86% 65
2023 Q2 $681,780,050 $544,041,032 +$10,477,233 79.5% 63
2023 Q1 $668,248,900 $518,216,210 -$1,459,788 77.17% 66
2022 Q4 $670,642,600 $517,847,527 -$73,724,755 76.87% 65
2022 Q3 $660,636,500 $485,781,826 -$11,778,141 73.51% 61
2022 Q2 $686,359,000 $506,552,457 +$6,946,730 73.75% 56
2022 Q1 $659,788,150 $560,408,977 -$25,467,744 84.55% 48
2021 Q4 $678,223,000 $618,812,607 +$43,879,928 91.2% 57
2021 Q3 $619,927,980 $627,379,868 +$167,030,114 100.71% 51
2021 Q2 $471,092,000 $530,179,568 +$530,179,920 112.32% 47
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .